Home » Market News » DirectorsTalk Highlights » How to attend Turner Pope Investments Investor Evening – Monday 13th May 2019

How to attend Turner Pope Investments Investor Evening – Monday 13th May 2019

Turner Pope Investments will be holding an Investor Evening this Monday 13th May 2019. With spaces limited it is important you reserve your spot via the email address at bottom.

The Saloon, The Ned Hotel (www.thened.com), 27 Poultry, London, EC2R 8AJ – Doors Open at 5.00pm for registration and refreshments with the first presentation to start at 5.30pm.

Presenting on the night, in alphabetical order:

Deltex Medical Group PLC – (LON: DEMG) – Having overseen a dramatic reduction in costs and a swing to operating profit, new Chief Executive Andy Mears will present his plans to grow this unique blood flow monitoring company.

Integumen PLC (LON: SKIN) – Chief Executive Gerry Brandon will present the positive steps taken to refocus Integumen as a virtual microbiology testing company and run through the rationale for the recent acquisition of Rinocloud.

Midatech Pharma PLC (LON: MTPH) – Following a very successful Placing and Open Offer, CFO Nick Robbins-Cherry will explain how the funds are being used developing this novel oncology and rare disease therapy business.

OptiBiotix Health PLC (LON: OPTI) – After a series of positive announcements, we welcome back CEO Stephen O’Hara to provide an update on the Company’s commercial advances in the human microbiome space.

WideCells Group PLC (LON: WDC) – To be renamed Iconic Labs, CEO John Quinlan will provide an overview of the newly-established new media and technology business and its growth strategy.

Spaces are very limited and we will be providing refreshments on the evening

info@turnerpope.com to register interest.

We suggest a smart-casual attire on the evening.

TPI arranges such events to provide Directors and shareholders alike with a forum to engage and network.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.